ArticleArchives of rehabilitation research and clinical translation2025
Walking Function and Capacity in Middle-Aged and Older (59-66y) Adults With Spina Bifida Myelomeningocele: A 4-Year Follow-up Study.
Article in Archives of rehabilitation research and clinical translation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To present a 4-year follow-up study on walking function and capacity in adults with spina bifida myelomeningocele (SBM) aged 59-66 years. Design: A 4-year follow-up study. Setting: A rehabilitation hospital. Participants: Ten middle-aged and older adults (59-66y) with SBM (N = 10), with walking ability, from a cross-sectional study of 19 participants in 2017. Five participants from 2017 were excluded due to medical reasons; 1 had lost walking ability and 3 had died. Interventions: Not applicable. Main Outcome Measures: Instrumented 10-m walk test, 6-minute walk test (6MWT), and fatigue severity scale. Results: The distance on the 6MWT decreased by more than 30 m in 5 out of 10 participants over the 4 years, whereas walking speed on the instrumented 10-m gait analysis decreased (>0.1m/s) in only 3 participants. Further, those with reduced walking capacity during the last 4 years also experienced increasing symptoms of fatigue and reported a self-perceived reduction in walking function. Conclusions: This is the first follow-up study of people with SMB without hydrocephalus aged 59-66 years to capture changes in their walking function by using objective measures in a motion laboratory and self-reported measures. This study revealed a change in half of the persons on the 6MWT and not to the same extent in the 10-m instrumented gait analysis test during the follow-up period. This may reflect that the 6MWT is more useful in detecting changes in walking capacity in this group. In conclusion, the study highlights the need for long-term follow-up for adults with SBM to maintain optimal walking capacity for more years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.